NORTHERN TRUST CORP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 242 filers reported holding CONMED CORP in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$34,221,633
-25.5%
339,332
+0.3%
0.01%
-22.2%
Q2 2023$45,960,308
+34.7%
338,217
+3.0%
0.01%
+28.6%
Q1 2023$34,111,155
+19.4%
328,434
+1.9%
0.01%
+16.7%
Q4 2022$28,557,149
+14.2%
322,170
+3.3%
0.01%0.0%
Q3 2022$25,015,000
-14.8%
312,008
+1.7%
0.01%0.0%
Q2 2022$29,367,000
-37.9%
306,668
-3.7%
0.01%
-25.0%
Q1 2022$47,303,000
+1.0%
318,426
-3.6%
0.01%0.0%
Q4 2021$46,826,000
+7.3%
330,309
-1.0%
0.01%0.0%
Q3 2021$43,646,000
-8.4%
333,610
-3.8%
0.01%0.0%
Q2 2021$47,663,000
+6.8%
346,816
+1.5%
0.01%0.0%
Q1 2021$44,640,000
+12.2%
341,829
-3.7%
0.01%0.0%
Q4 2020$39,773,000
+38.3%
355,110
-2.9%
0.01%
+33.3%
Q3 2020$28,759,000
+3.5%
365,562
-5.3%
0.01%
-14.3%
Q2 2020$27,790,000
-24.6%
386,013
-40.0%
0.01%
-36.4%
Q1 2020$36,866,000
-48.4%
643,726
+0.8%
0.01%
-31.2%
Q4 2019$71,401,000
+14.5%
638,482
-1.6%
0.02%
+6.7%
Q3 2019$62,359,000
+18.9%
648,558
+5.9%
0.02%
+25.0%
Q2 2019$52,425,000
+4.5%
612,644
+1.6%
0.01%0.0%
Q1 2019$50,157,000
+29.0%
602,973
-0.4%
0.01%
+9.1%
Q4 2018$38,882,000
-18.9%
605,643
+0.0%
0.01%
-8.3%
Q3 2018$47,955,000
+6.2%
605,347
-1.8%
0.01%
+9.1%
Q2 2018$45,137,000
+14.5%
616,625
-0.9%
0.01%
+10.0%
Q1 2018$39,415,000
+23.7%
622,378
-0.4%
0.01%
+25.0%
Q4 2017$31,861,000
-3.6%
625,095
-0.7%
0.01%
-11.1%
Q3 2017$33,043,000
+1.2%
629,766
-1.7%
0.01%0.0%
Q2 2017$32,645,000
+26.1%
640,851
+10.0%
0.01%
+28.6%
Q1 2017$25,882,000
+1.4%
582,796
+0.9%
0.01%
-12.5%
Q4 2016$25,521,000
+12.0%
577,787
+1.5%
0.01%
+14.3%
Q3 2016$22,794,000
-14.3%
568,982
+2.1%
0.01%
-22.2%
Q2 2016$26,609,000
+15.0%
557,504
+1.5%
0.01%
+12.5%
Q1 2016$23,144,000
-2.9%
549,242
+1.6%
0.01%0.0%
Q4 2015$23,823,000
-8.2%
540,798
-0.6%
0.01%
-11.1%
Q3 2015$25,964,000
-8.5%
543,844
+11.7%
0.01%0.0%
Q2 2015$28,364,000
-47.3%
486,760
-54.4%
0.01%
-43.8%
Q1 2015$53,856,000
+11.9%
1,066,652
-0.4%
0.02%
+6.7%
Q4 2014$48,131,000
+21.4%
1,070,527
-0.5%
0.02%
+25.0%
Q3 2014$39,650,000
-13.6%
1,076,296
+3.6%
0.01%
-14.3%
Q2 2014$45,883,000
+1.7%
1,039,260
+0.1%
0.01%0.0%
Q1 2014$45,104,000
+1.1%
1,038,062
-1.1%
0.01%0.0%
Q4 2013$44,607,000
+29.6%
1,049,588
+3.6%
0.01%
+16.7%
Q3 2013$34,417,000
+10.6%
1,013,420
+1.7%
0.01%
+9.1%
Q2 2013$31,118,000996,0770.01%
Other shareholders
CONMED CORP shareholders Q3 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders